Biopharmatek SRL
Biopharmatek reported total assets of 415,535 € at the end of the 2025 financial year (annual accounts filed with the NBB on 19 Jun 2026).
The score of Biopharmatek shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +50 % Total assets -57 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Biopharmatek's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 51,822 € | ||||
| Equity | 280,092 € | ||||
| Cash | 258,274 € | ||||
| EBITDA | 64,427 € | ||||
| Total assets | 415,535 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 19 Jun 2026
- Year ended 31 Dec 2024filed on 29 Jul 2025
- Year ended 31 Dec 2023filed on 29 Jul 2024
- Year ended 31 Dec 2022filed on 24 Jul 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Biopharmatek's financial analysis
- Solvency67.4%sector median: 22.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Biopharmatek
Biopharmatek's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0675.688.340
- VAT number
- BE0675688340
- Peppol
- Registered · 0208:0675688340 · as of 11 Nov 2026
- Legal form
- SRL
- Incorporated
- 12 May 2017
- Registered office
- 1200 Woluwe-Saint-Lambert
- Latest accounts
- 2025 · filed on 19 Jun 2026
- Activity
- Activities of agents involved in the wholesale of other particular products (NACE 46180)
Biopharmatek (SRL) has been based in Woluwe-Saint-Lambert since 2017, active in: activities of agents involved in the wholesale of other particular products. For 2025, it reports a net profit of 51,822 € and equity of 280,092 €; its revenue is not published. Its solvency stands at 67.4%, above the median of its sector (22.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Biopharmatek
Companies in the same business, of comparable size and area, outside its group.
- Trilogiq Benelux Activities of agents involved in the wholesale of other particular products Watermael-Boitsfort · balance sheet 158,075 €
- 4U Consultancy Activities of agents involved in the wholesale of other particular products Auderghem · balance sheet 68,292 €
- David Activities of agents involved in the wholesale of other particular products Wellen · balance sheet 461,225 €
- Fieldtrust Activities of agents involved in the wholesale of other particular products Temse · balance sheet 884,484 €
- Hd & m Group Activities of agents involved in the wholesale of other particular products Schaerbeek · balance sheet 118,919 €
- Olaf Cool Products Activities of agents involved in the wholesale of other particular products Zemst · balance sheet 303,698 €
- SoBeCo Activities of agents involved in the wholesale of other particular products Tournai · balance sheet 309,563 €
- Ware*Ever Wholesale of information and communication equipment Tielt · balance sheet 392,505 €
Frequently asked questions about Biopharmatek
What is the revenue of Biopharmatek?
Biopharmatek files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Biopharmatek?
In Belgium, the VAT number is the company number prefixed with BE: BE0675688340 for Biopharmatek, if the company is VAT-registered. Its company number (CBE) is 0675.688.340.
Where is the registered office of Biopharmatek?
According to the CBE register, the registered office of Biopharmatek is in 1200 Woluwe-Saint-Lambert.
What is the equity of Biopharmatek?
At the close of the 2025 financial year, the equity of Biopharmatek amounts to 280,092 €, a solvency of 67.4% of total assets.
Who manages Biopharmatek?
The register lists 1 active mandates at Biopharmatek. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Biopharmatek
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →